Clinical Trials Browser

OTHER × Thymus Neoplasms × palbociclib × Clear all

NCT03219554 2017-08-02

A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor

Phase 2 Unknown

Thymus Neoplasms